Advanced GI and Bariatric Surgery Division, Department of Surgery, Mayo Clinic, Jacksonville, Florida, U.S.A.
Division of Health Care Delivery Research, Mayo Clinic, Robert D. and Patricia E. Kern Center, Jacksonville, Florida, U.S.A.
Laryngoscope. 2024 Mar;134(3):1169-1182. doi: 10.1002/lary.31041. Epub 2023 Sep 23.
The aim was to determine the utilization of Caprini guideline-indicated venous thromboembolism (VTE) prophylaxis and impact on VTE and bleeding outcomes in otolaryngology (ORL) surgery patients.
Elective ORL surgeries performed between 2016 and 2021 were retrospectively identified. Logistic regression models were used to examine the association between patient characteristics and receiving appropriate prophylaxis, inpatient, 30- and 90-day VTE and bleeding events.
A total of 4955 elective ORL surgeries were analyzed. Thirty percent of the inpatient cohort and 2% of the discharged cohort received appropriate risk-stratified VTE prophylaxis. In those who did not receive appropriate prophylaxis, overall inpatient VTE was 3.5-fold higher (0.73% vs. 0.20%, p = 0.015), and all PE occurred in this cohort (0.47% vs. 0.00%, p = 0.005). All 30- and 90-day discharged VTE events occurred in those not receiving appropriate prophylaxis. Inpatient, 30- and 90-day discharged bleeding rates were 2.10%, 0.13%, and 0.33%, respectively. Although inpatient bleeding was significantly higher in those receiving appropriate prophylaxis, all 30- and 90-day post-discharge bleeding events occurred in patients not receiving appropriate prophylaxis. On regression analysis, Caprini score was significantly positively associated with likelihood of receiving appropriate inpatient prophylaxis (odds ratio [OR] 1.05, confidence interval [CI] 1.03-1.07) but was negatively associated in the discharge cohort (OR 0.43, CI 0.36-0.51). Receipt of appropriate prophylaxis was associated with reduced odds of inpatient VTE (OR 0.24, CI 0.06-0.69), but not with risk of bleeding.
Although Caprini VTE risk-stratified prophylaxis has a positive impact in reducing inpatient and post-discharge VTE, it must be balanced against the risk of inpatient postoperative bleeding.
3 Laryngoscope, 134:1169-1182, 2024.
旨在确定卡普里尼指南指示的静脉血栓栓塞症(VTE)预防的利用情况,并评估其对耳鼻喉科(ORL)手术患者 VTE 和出血结局的影响。
回顾性分析 2016 年至 2021 年间进行的择期 ORL 手术。使用逻辑回归模型来研究患者特征与接受适当预防措施、住院、30 天和 90 天 VTE 和出血事件之间的关联。
共分析了 4955 例择期 ORL 手术。在住院患者队列中,有 30%和出院患者队列中 2%接受了适当的风险分层 VTE 预防措施。在未接受适当预防措施的患者中,总体住院 VTE 风险高 3.5 倍(0.73% vs. 0.20%,p=0.015),并且所有的肺栓塞均发生在该队列中(0.47% vs. 0.00%,p=0.005)。所有出院 30 天和 90 天的 VTE 事件均发生在未接受适当预防措施的患者中。住院、30 天和 90 天出院出血率分别为 2.10%、0.13%和 0.33%。尽管接受适当预防措施的患者住院出血率显著更高,但所有出院 30 天和 90 天的出血事件均发生在未接受适当预防措施的患者中。在回归分析中,卡普里尼评分与接受适当住院预防措施的可能性显著正相关(优势比[OR] 1.05,置信区间[CI] 1.03-1.07),但在出院队列中呈负相关(OR 0.43,CI 0.36-0.51)。接受适当预防措施与住院 VTE 风险降低相关(OR 0.24,CI 0.06-0.69),但与出血风险无关。
尽管卡普里尼 VTE 风险分层预防措施在降低住院和出院后 VTE 方面具有积极影响,但必须权衡其与住院术后出血风险之间的关系。
3 级。喉镜,134:1169-1182,2024。